Ohio’s Eli Lilly Wins Patent Lawsuit Against Janssen Involving Alzheimer’s Treatment

Circle Connections: New Products & Services Eli Lilly & Co. won a U.K. patent lawsuit against a Johnson & Johnson unit over a potential treatment for Alzheimer's disease. A patent held by New Brunswick- based J&Js Janssen Alzheimer Immunotherapy Research & Development unit isn't valid, Judge Richard Arnold said in a ruling in London today. Both companies are developing treatments targeting the build-up of plaque in patients brains that's linked to the condition. Companies developing the first treatments for Alzheimer's are competing for what might be a $20 billion market, according to . . .